Altimmune, Inc. (ALT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 150K 300K 450K Q1 '24: 410K Q2 '24: 409K Q3 '24: 52K Q4 '24: 20K Q1 '25: 20K Q2 '25: 20K Q3 '25: 20K Q4 '25: 41K Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-120M -80M -40M 0 40M 80M 120M Q3 '24: -111.9M Q4 '24: -103.2M Q1 '25: -98.2M Q2 '25: -94.4M Q3 '25: -90.5M Q4 '25: -94.5M Q1 '26: -96.9M Q2 '26: -100.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-120M -80M -40M 0 40M 80M 120M Q3 '24: -103.5M Q4 '24: -95.1M Q1 '25: -90.2M Q2 '25: -87.7M Q3 '25: -83.9M Q4 '25: -88.1M Q1 '26: -91.1M Q2 '26: -91.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-90M -60M -30M 0 30M 60M 90M Q3 '24: -78.1M Q4 '24: -79.8M Q1 '25: -80.3M Q2 '25: -81.6M Q3 '25: -66.4M Q4 '25: -67.5M Q1 '26: -71.6M Q2 '26: -76.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-90M -60M -30M 0 30M 60M 90M Q2 '22: -70.2M Q3 '22: -67.5M Q4 '22: -62.7M Q1 '23: -68.6M Q2 '23: -71.3M Q3 '23: -76.7M Q4 '23: -75.9M Q2 '26: -76.6M Q2 '22 Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q1 '24: 70.8M Q2 '24: 70.9M Q3 '24: 71.1M Q1 '25: 75.5M Q2 '25: 81.5M Q3 '25: 89.4M Q1 '26: 124.5M Q2 '26: 185.4M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.80 -1.20 -0.60 0.00 0.60 1.20 1.80 Q3 '24: -1.57 Q4 '24: -1.34 Q1 '25: -1.26 Q2 '25: -1.18 Q3 '25: -1.07 Q4 '25: -1.00 Q1 '26: -0.92 Q2 '26: -0.77 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.